Allergen manufacturing and quality aspects for allergen immunotherapy in Europe and the United States: An analysis from the EAACI AIT Guidelines Project. (Q47833107)
Jump to navigation
Jump to search
scientific article published on 17 November 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Allergen manufacturing and quality aspects for allergen immunotherapy in Europe and the United States: An analysis from the EAACI AIT Guidelines Project. |
scientific article published on 17 November 2017 |
Statements
Allergen manufacturing and quality aspects for allergen immunotherapy in Europe and the United States: An analysis from the EAACI AIT Guidelines Project (English)
L Klimek
J E Slater
J Bridgewater
R L Rabin
M Hoefnagel
M Timon
C Pini
C Akdis
J Goldstein
L K Poulsen
R van Ree
C Rhyner
O Palomares
R Pawankar
D Hamerlijnk
I Agache
E Angier
T Casale
M Fernandez-Rivas
S Lau
G Pajno
G Sturm
E M Varga
R Gerth van Wijk
A Muraro
S Vieths
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference